PKM2‐Y105 is activated by kinase phosphorylation to exert oncogenic function, partly by activating YAP downstream signal transduction to increase the characteristics of cancer stem cell‐like cells in breast cancer cells.46 Here, PKM is linked to breast carcinoma.